Generic medications. “Bottle of Lies” and what I have recently learned.

Posted on February 25, 2020

So I am in a book club. It is all women physicians (different specialties- Pediatrics, Surgery, Family Practice, Internal Medicine, Radiology, OB-Gyne- and settings- PA Clinic, Stanford, private practice, Santa Clara County Medical Center). We read all sorts of nonfiction books, but this time we read one about the generic drug industry called “Bottle of Lies.”

Wow.

Let me start by saying this is an investigative journalism piece, think of it like “The Jungle” (by Upton Sinclair) was for meatpacking plants.  What I found interesting is the book was a revelation to ALL of us.  Here we are, a group of hyper-educated physicians, and none of us knew how the generic drug industry developed. How are generics made? tested? safeguarded?  I have blogged countless times on the herbal industry, and how dangerous it is- many times you are not getting what you think. SEE BLOG HERE.

I thought real medications- generic or not- are FDA regulated and approved.  They are different. Tested. Clean. Known.

I am no longer so sure.

For those of you who won’t read the book, (but I highly recommend it. It reads like a fast paced thriller, with lies, subterfuge, and lots of money and market share.) let me summarize some things.

What should you do?

Generics are here to stay. In the effort to keep medicine costs down, there is pressure for generic medicine and it has made medicines more affordable to millions.  Generics must work to some extent, as generics for cholesterol, blood pressure,  antibiotics,and heart arrhythmias have been in use for a while.  But all generics are not created equal.

Sure this book is one sided.  But the issue is real. I have friends who tell me, “my medicine is no longer working” or “I couldn’t take that medicine as it caused memory issues.” But which medicine was it? Was it the name brand? A generic? WHICH generic?

As physicians, my book club was stunned.  None of us had heard of these pervasive issues- just the occasional “bad batch” stories.  None of us had understood in detail how generics were developed.

The back cover of Bottle of Lies:

“From an award-winning journalist, an explosive narrative investigation of the generic drug boom that reveals fraud and life-threatening dangers on a global scale—….. Today, 90 percent of our pharmaceutical market is comprised of generics, the majority of which are manufactured overseas. We have been reassured by our doctors, our pharmacists, and our regulators that generic drugs are identical to their brand-name counterparts, just less expensive. But is this really true?
Katherine Eban’s Bottle of Lies exposes the deceit behind generic drug manufacturing—and the attendant risks for global health. Drawing on exclusive accounts from whistleblowers and regulators, as well as thousands of pages of confidential FDA documents, Eban reveals an industry where fraud is rampant, companies routinely falsify data, and executives circumvent almost every principle of safe manufacturing to minimize cost and maximize profit, confident in their ability to fool inspectors. Meanwhile, patients unwittingly consume medicine with unpredictable and dangerous effects.”